Abstract: The present technology relates to biocidal compositions and methods that contain and utilize at least one biocidal agent and at least one potentiator system wherein the resultant combination has an enhanced biocidal efficacy. The present technology also discloses a rapid screening assay for determining biocidal compositions with enhanced efficacy, e.g., a microbial contact kill time of 5 minutes or less. Further, the present technology provides a method of determining biocidally effective concentrations of biocidal compositions comprising at least one biocidal agent and at least one potentiator system.

Abstract: An array of two or more tunable electro-optical reflecting elements where the phase response of one or more elements may be adjusted by a variety of approaches including, but not limited to: a liquid crystal superstrate, schottky contact(s), ultra-violet radiation pulses, and illumination of photoconductive substrates. Methods and apparatus for direct and/or adaptive control of phase response via the above approaches are also discussed.

Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.

Abstract: Wing in ground effect vehicles operate near the surface to acquire benefits in aerodynamic performance. However, a lack of sufficient stability has been a frequent limitation for such vehicles. The disclosed invention is a wing in ground effect vehicle that comprises a plurality of mechanical devices to acquire stability in roll and height with respect to the surface. Each device comprises a pivotally mounted aerodynamic lifting surface, surface contacting element, and interconnecting structure. The disclosed arrangement of these components actively determines the angle of attack of the aerodynamic lifting surfaces and produces vehicle stability in roll and height with respect to the surface.

Abstract: The invention features methods and compositions for preventing or treating post-surgical pain by administering an anti-NGF antagonist antibody.

Abstract: The invention concerns agonist anti-trkC monoclonal antibodies which mimic certain biological activities of NT-3, the native ligand of trkC. The invention further concerns the use of such antibodies in the prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy.

Abstract: This invention relates to the field of taxol-induced gut disorder. More specifically, the invention relates to methods of treating taxol-induced gut disorder comprising administration of agonist anti-trkC antibody for the treatment, prevention, and/or amelioration of a symptom of taxol-induced gut disorder.

Abstract: This invention relates to the field of cardiac disease. More specifically, the invention relates to methods using an NGF antagonist for treating and preventing cardiac arrhythmia and methods of preventing death due to cardiac arrhythmia.

Abstract: Dual, diagonal bars to reduce vehicle roll and pitch rates, thereby stabilizing the vehicle, are disclosed. One bar attaches linking the left front suspension to the right rear suspension, and the other bar links the right front suspension and the left rear suspension. Attachment points link alternate corners rather than being on the same axle. The bars are attached to the suspension with additional attachment to either the suspension or the chassis. The primary means of mounting, or attaching, the bars is in at least four spots for each bar. There may be a need to add one additional mount, or more, per bar along the long section of the bar between the front and rear chassis mounts to control flex and provide a more pleasant ride. The opposing end of the bar is attached to the rear suspension outboard near the spring mount on a live rear axle, or on the control arm of an independent rear suspension. A sleeve could replace the two mounts that are on the suspension.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention concerns the use of artemin for the prevention or treatment of nerve cell injury and changes associated with nerve cell injury. More particularly the present invention provides for a method of protecting neurons in a mammal from injury-induced pathological changes and a method of treating neuronal damage in a mammal by administering artemin or an artemin agonist.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: A apparatus for cooling concrete while inside the concrete mixing chamber with a space related outer covering consisting of sections of mild steel welded around an existing portable mixing tank, a chamber access door located in the upper most rear of the mixing chamber for insertion of ice or CO2 pellets, a locking mechanism for securing the chamber door, a check valve located adjacent to the chamber access door for release of CO2 gases, a ball valve located at a 180 degree angle and on the opposite end of the mixing chamber from the access door for drainage of melted ice and a preferred embodiment includes the covering is made of galvanized iron, as well as stainless steel.

Abstract: This invention relates to the field of taxol-induced neuropathy. More specifically, the invention relates to methods of treating taxol-induced sensory neuropathy comprising administration of agonist anti-trkC antibody for the treatment, prevention, and/or amelioration of a symptom of taxol-induced sensory neuropathy.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Abstract: A wooden member support retrofit system includes a wooden member support having a support base and a wooden member supported by the wooden member. The system also includes a shim disposed in a space formed between the base and the wooden member due to relative movement of the base and the wooden member over time. A process of retrofitting a wooden member support system includes measuring a space formed between a base of a wooden member support and a wooden member due to relative movement of the base and the wooden member over time. The system includes selecting a shim and placing the shim in the space formed between the base and the wooden member.